DaVita (DVA) Revenue & Revenue Breakdown
DaVita Revenue Highlights
Latest Revenue (Y)
$12.14B
Latest Revenue (Q)
$3.19B
Main Segment (Y)
U S Dialysis And Related Lab Services
DaVita Revenue by Period
DaVita Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $12.14B | 4.57% |
| 2022-12-31 | $11.61B | -0.08% |
| 2021-12-31 | $11.62B | 0.59% |
| 2020-12-31 | $11.55B | 1.42% |
| 2019-12-31 | $11.39B | -0.14% |
| 2018-12-31 | $11.40B | 4.86% |
| 2017-12-31 | $10.88B | -26.24% |
| 2016-12-31 | $14.75B | 6.99% |
| 2015-12-31 | $13.78B | 7.71% |
| 2014-12-31 | $12.80B | 8.76% |
| 2013-12-31 | $11.76B | 43.70% |
| 2012-12-31 | $8.19B | 20.53% |
| 2011-12-31 | $6.79B | 5.34% |
| 2010-12-31 | $6.45B | 5.54% |
| 2009-12-31 | $6.11B | 7.93% |
| 2008-12-31 | $5.66B | 7.52% |
| 2007-12-31 | $5.26B | 7.86% |
| 2006-12-31 | $4.88B | 64.12% |
| 2005-12-31 | $2.97B | 29.38% |
| 2004-12-31 | $2.30B | 12.32% |
| 2003-12-31 | $2.05B | 10.34% |
| 2002-12-31 | $1.85B | 12.35% |
| 2001-12-31 | $1.65B | 11.06% |
| 2000-12-31 | $1.49B | 2.83% |
| 1999-12-31 | $1.45B | 19.96% |
| 1998-12-31 | $1.20B | 174.97% |
| 1997-12-31 | $438.20M | 60.57% |
| 1996-12-31 | $272.90M | 204.24% |
| 1995-12-31 | $89.70M | - |
DaVita generated $12.14B in revenue during NA 2023, up 4.57% compared to the previous quarter, and up 106.45% compared to the same period a year ago.
DaVita Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $3.19B | 3.78% |
| 2024-03-31 | $3.07B | -2.39% |
| 2023-12-31 | $3.15B | 0.78% |
| 2023-09-30 | $3.12B | 4.03% |
| 2023-06-30 | $3.00B | 4.44% |
| 2023-03-31 | $2.87B | -1.51% |
| 2022-12-31 | $2.92B | -1.08% |
| 2022-09-30 | $2.95B | 0.75% |
| 2022-06-30 | $2.93B | 3.88% |
| 2022-03-31 | $2.82B | -4.29% |
| 2021-12-31 | $2.94B | 0.19% |
| 2021-09-30 | $2.94B | 0.75% |
| 2021-06-30 | $2.92B | 3.42% |
| 2021-03-31 | $2.82B | -2.94% |
| 2020-12-31 | $2.91B | -0.64% |
| 2020-09-30 | $2.92B | 1.53% |
| 2020-06-30 | $2.88B | 1.36% |
| 2020-03-31 | $2.84B | -1.98% |
| 2019-12-31 | $2.90B | -0.19% |
| 2019-09-30 | $2.90B | 2.16% |
| 2019-06-30 | $2.84B | 3.63% |
| 2019-03-31 | $2.74B | -2.77% |
| 2018-12-31 | $2.82B | -0.92% |
| 2018-09-30 | $2.85B | -1.37% |
| 2018-06-30 | $2.89B | 1.32% |
| 2018-03-31 | $2.85B | 2.46% |
| 2017-12-31 | $2.78B | -29.11% |
| 2017-09-30 | $3.92B | 1.17% |
| 2017-06-30 | $3.88B | 4.87% |
| 2017-03-31 | $3.70B | -0.50% |
| 2016-12-31 | $3.72B | -0.40% |
| 2016-09-30 | $3.73B | 0.35% |
| 2016-06-30 | $3.72B | 3.81% |
| 2016-03-31 | $3.58B | 1.35% |
| 2015-12-31 | $3.53B | 0.22% |
| 2015-09-30 | $3.53B | 2.65% |
| 2015-06-30 | $3.43B | 4.46% |
| 2015-03-31 | $3.29B | -1.20% |
| 2014-12-31 | $3.33B | 2.34% |
| 2014-09-30 | $3.25B | 2.50% |
| 2014-06-30 | $3.17B | 4.26% |
| 2014-03-31 | $3.04B | -0.67% |
| 2013-12-31 | $3.06B | 2.12% |
| 2013-09-30 | $3.00B | 4.45% |
| 2013-06-30 | $2.87B | 1.49% |
| 2013-03-31 | $2.83B | 16.59% |
| 2012-12-31 | $2.43B | 23.64% |
| 2012-09-30 | $1.96B | 1.72% |
| 2012-06-30 | $1.93B | 3.38% |
| 2012-03-31 | $1.87B | 0.23% |
| 2011-12-31 | $1.86B | 3.01% |
| 2011-09-30 | $1.81B | 5.63% |
| 2011-06-30 | $1.71B | 6.57% |
| 2011-03-31 | $1.61B | -2.63% |
| 2010-12-31 | $1.65B | -0.01% |
| 2010-09-30 | $1.65B | 3.95% |
| 2010-06-30 | $1.59B | 1.76% |
| 2010-03-31 | $1.56B | -0.56% |
| 2009-12-31 | $1.57B | -0.36% |
| 2009-09-30 | $1.57B | 3.61% |
| 2009-06-30 | $1.52B | 4.93% |
| 2009-03-31 | $1.45B | -0.92% |
| 2008-12-31 | $1.46B | 0.96% |
| 2008-09-30 | $1.45B | 2.83% |
| 2008-06-30 | $1.41B | 4.65% |
| 2008-03-31 | $1.34B | -0.75% |
| 2007-12-31 | $1.35B | - |
DaVita generated $3.19B in revenue during Q2 2024, up 3.78% compared to the previous quarter, and up 110.93% compared to the same period a year ago.
DaVita Revenue Breakdown
DaVita Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| U S Dialysis And Related Lab Services | $10.94B | $10.51B | $10.58B | $10.51B | $10.43B |
| Other Segments | $1.30B | $1.10B | $1.04B | $1.04B | $957.90M |
DaVita's latest annual revenue breakdown by segment (product or service), as of Dec 23: U S Dialysis And Related Lab Services (89.38%), and Other Segments (10.62%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Segments | $341.61M | $363.98M | $362.55M | $290.12M | $282.59M | $281.19M | $268.40M | $282.91M | $264.63M | $261.64M | $262.38M | $261.49M | $257.13M | $271.47M | $267.16M | $240.46M | $256.86M | $250.74M | $245.01M | $235.54M |
| U S Dialysis And Related Lab Services | $2.76B | $2.85B | $2.79B | $2.71B | $2.59B | $2.64B | $2.68B | $2.64B | $2.55B | $2.68B | $2.68B | $2.66B | $2.56B | $2.63B | $2.66B | $2.64B | $2.58B | $2.65B | $2.66B | $2.61B |
DaVita's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: U S Dialysis And Related Lab Services (88.97%), and Other Segments (11.03%).
DaVita Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HCA | HCA Healthcare | $64.97B | $17.49B |
| THC | Tenet Healthcare | $20.55B | $5.10B |
| UHS | Universal Health Services | $14.28B | $3.91B |
| CYH | Community Health Systems | $12.49B | $3.14B |
| DVA | DaVita | $12.14B | $3.19B |
| EHC | Encompass Health | $4.80B | $1.30B |
| OPCH | Option Care Health | $4.30B | $1.23B |
| AMN | AMN Healthcare Services | $3.79B | $740.68M |
| ENSG | Ensign Group | $3.73B | $1.04B |
| ACHC | Acadia Healthcare Company | $2.93B | $796.04M |
| SGRY | Surgery Partners | $2.74B | $762.10M |
| AMED | Amedisys | $2.24B | $591.19M |
| USPH | U.S. Physical Therapy | $514.56M | $167.19M |
DVA Revenue FAQ
What is DaVita’s yearly revenue?
DaVita's yearly revenue for 2023 was $12.14B, representing an increase of 4.57% compared to 2022. The company's yearly revenue for 2022 was $11.61B, representing a decrease of -0.08% compared to 2021. DVA's yearly revenue for 2021 was $11.62B, representing an increase of 0.59% compared to 2020.
What is DaVita’s quarterly revenue?
DaVita's quarterly revenue for Q2 2024 was $3.19B, a 3.78% increase from the previous quarter (Q1 2024), and a 6.21% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.07B, a -2.39% decrease from the previous quarter (Q4 2023), and a 6.89% increase year-over-year (Q1 2023). DVA's quarterly revenue for Q4 2023 was $3.15B, a 0.78% increase from the previous quarter (Q3 2023), and a 7.85% increase year-over-year (Q4 2022).
What is DaVita’s revenue growth rate?
DaVita's revenue growth rate for the last 3 years (2021-2023) was 4.49%, and for the last 5 years (2019-2023) was 6.60%.
What are DaVita’s revenue streams?
DaVita's revenue streams in c 23 are U S Dialysis And Related Lab Services, and Other Segments. U S Dialysis And Related Lab Services generated $10.94B in revenue, accounting 89.38% of the company's total revenue, up 4.04% year-over-year. Other Segments generated $1.3B in revenue, accounting 10.62% of the company's total revenue, up 18.42% year-over-year.
What is DaVita’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of DaVita was U S Dialysis And Related Lab Services. This segment made a revenue of $10.94B, representing 89.38% of the company's total revenue.